Company Nanologica AB

NICA

SE0005454873

Commodity Chemicals

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2025-07-14 pm EDT			5-day change	1st Jan Change
1.200 ^SEK	+5.26%		+8.11%	-34.07%

Jul. 10	Nanologica AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
Jul. 10	Nanologica Increases Revenue but Reports Wider Operating Loss	FW

Business description: Nanologica AB

Nanologica AB (publ) is a Sweden-based materials development company. The Company specializes in developing nanoporous materials from nanoporous silica (silicon dioxide) for a variety of applications, ranging from purification to pharmaceutical excipients. The Company's core competency has been developed and expanded in two areas of application, in particular: Drug Delivery and Chromatography, a technology used for the separation and purification of products on the market and in development. The Company's Drug Delivery sector operates within a niche domain of nanocarriers. Nanologica AB (publ)âs drug delivery technology is aimed on absorption of the medicine by the body for drugs that are poorly soluble in water.

Number of employees: 16

Sales by Activity: Nanologica AB

Fiscal Period: December	2020	2021	2022	2023	2024
Chroma	4.47M	1.91M	1.56M	1.44M	-
Unallocated Business Support	-	642K	-	-	-
Drug Development - DD	11.67M	10.36M	-	-	-

See all business segments

Geographical breakdown of sales: Nanologica AB

Fiscal Period: December	2020	2021	2022	2023	2024
China	3.32M	1.31M	699K	654K	8.43M
India	-	-	-	188K	5.92M
Rest of The World	2.36M	1.62M	182K	601K	175K
USA	410K	103K	276K	-	21K
Turkey	-	-	398K	-	-
Corporate	-	642K	-	-	-
Sweden	10.04M	9.24M	-	-	-

See all geographic segments

Executive Committee: Nanologica AB

Manager	Title	Age	Since
Andreas Bhagwani CEO	Chief Executive Officer	50	2010-12-31
Eva Osterman DFI	Director of Finance/CFO	54	2016-12-31
Åsa Bergström COO	Chief Operating Officer	61	2024-04-30
Johanna Johansson IRC	Investor Relations Contact	-	-
Carita Jagenheim AUD	Comptroller/Controller/Auditor	-	-

See NANOLOGICA AB governance

Composition of the Board of Directors: Nanologica AB

Director	Title	Age	Since
Gisela Marie Sitbon CHM	Chairman	67	2013-12-31
Lena Margareta Torlegård BRD	Director/Board Member	62	2013-12-31
Mattias Bengtsson BRD	Director/Board Member	56	2018-12-31
Anders Rabbe BRD	Director/Board Member	55	2019-12-31
Thomas Bengt Eldered BRD	Director/Board Member	65	2020-12-31

Composition of the Board of Directors

Shareholders: Nanologica AB

Name	Equities	%	Valuation
FCG Fonder AB 0.2807 %	248,019	0.2807 %	30 189 kr

List of NANOLOGICA AB shareholders

Company details: Nanologica AB

Nanologica AB

Forskargatan 20G

151 36, Södertälje

+46 8 41 07 49 49

http://www.nanologica.com

Plastics

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
NANOLOGICA AB	+5.26%	+8.11%	-79.87%	-89.61%	10.56M
BOROUGE PLC	0.00%	-0.38%	+11.11%	-7.14%	21.26B
DOW INC.	-4.40%	+2.80%	-46.97%	-42.23%	20.89B
LG CHEM, LTD.	+0.55%	+3.40%	-25.58%	-47.10%	14.78B
COVESTRO AG	-0.13%	-0.10%	+10.09%	+88.76%	13.36B
FORMOSA PLASTICS CORPORATION	+5.00%	-1.65%	-38.34%	-58.34%	7.41B
THE SUPREME INDUSTRIES LIMITED	-0.05%	-3.59%	-28.99%	+123.97%	6.09B
HANGZHOU FIRST APPLIED MATERIAL CO., LTD.	-2.10%	-0.52%	-11.29%	-60.19%	5.02B
FORMOSA CHEMICALS & FIBRE CORPORATION	+3.61%	-3.97%	-52.83%	-65.38%	4.43B
YUNNAN ENERGY NEW MATERIAL CO., LTD.	-0.18%	-1.08%	-7.07%	-87.55%	3.84B
Average	+0.75%	+0.27%	-26.97%	-24.48%	9.71B
Weighted average by Cap.	-0.46%	+1.40%	-18.20%	-11.84%